Protocolo diagnóstico de las canalopatías

  1. Pascual Izco, M.
  2. Valverde Gómez, M.
  3. Zamorano Gómez, J.L.
Revista:
Medicine: Programa de Formación Médica Continuada Acreditado

ISSN: 0304-5412

Año de publicación: 2017

Título del ejemplar: Enfermedades cardiológicas (V) Arritmias (II)

Serie: 12

Número: 39

Páginas: 2335-2337

Tipo: Artículo

DOI: 10.1016/J.MED.2017.07.015 DIALNET GOOGLE SCHOLAR

Otras publicaciones en: Medicine: Programa de Formación Médica Continuada Acreditado

Resumen

Resumen/Clasificación A la hora de hablar de canalopatías debemos centrarnos en cuatro entidades patológicas: el síndrome de Brugada, el síndrome de QT largo, el síndrome de QT corto y la taquicardia ventricular polimórfica catecolaminérgica. Diagnóstico En las cuatro entidades patológicas, el diagnóstico se establece en base a hallazgos electrocardiográficos y/o genéticos.

Referencias bibliográficas

  • Ackerman MJ, Priori SG, Willems S, Berul C, Brugada R, Calkins H. HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was deve-loped as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). Europace. 2011;13(8): 1077-109.
  • Arbustini E, Narula N, Dec GW, Reddy KS, Greenberg B, Kushwaha S. The MOGE(S) classification for a phenotype-genotype nomenclature of cardiomyopathy: endorsed by the World Heart Federation. J Am Coll Cardiol. 2013;62(22):2046-72.
  • Brugada R, Brugada J, Antzelevitch C, Kirsch GE, Potenza D, Towbin JA. Sodium channel blockers identify risk for sudden death in patients with ST-segment elevation and right bundle branch block but structura-lly normal hearts. Circulation. 2000;101(5):510.
  • Elliott P, Andersson B, Arbustini E, Bilinska Z, Cecchi F, Charron P. Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2008;29(2):270.
  • Giustetto C, Di Monte F, Wolpert C, Borggrefe M, Schimpf R, Sbraquia P. Short QT syndrome: clinical findings and diagnostic-therapeutic implications. Eur Heart J. 2006;27:2440.
  • Maron BJ, Towbin JA, Thiene G, Antzelevitch C, Corrado D, Arnett D, American Heart Association, Council on Clinical Cardiology, Heart Failure and Transplantation Committee, Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups, Council on Epidemiology and Prevention. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation. 2006;113(14):1807.
  • Moss AJ. Long QT Syndrome. JAMA. 2003;289:2041.
  • Nguyen PT, Scheinman MM, Seger J. Polymorphous ventricular tachycardia: clinical characterization, therapy, and the QT interval. Circulation. 1986;74:340.
  • Rossenbacker T, Priori SG. Clinical diagnosis of long QT syndrome: back to the caliper. Eur Heart J. 2007;28:527.
Fuente de los datos: Dialnet